Evidence map›Paper›PMID 34344890›Full record

ArticleNPJ Regenerative medicine2021

Driving regeneration, instead of healing, in adult mammals: the decisive role of resident macrophages through efferocytosis.

Lise Rabiller, Virginie Robert, Adèle Arlat, Elodie Labit, Marielle Ousset, Marie Salon, Agnès Coste, Léa Da Costa-Fernandes, Paul Monsarrat, Bruno Ségui and 11 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Efferocytosis in Homeostasis.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Healing Mechanisms in Cutaneous Wounds: Tipping the Balance.Tissue engineering. Part B, Reviews · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Lise Rabiller *STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0001-5563-4316
Virginie Robert *STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Adèle ArlatSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0003-2868-2165
Elodie LabitSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Marielle OussetSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Marie SalonUMR 152 Pharma Dev, Université de Toulouse, IRD, UPS, Toulouse, France.
Agnès CosteUMR 152 Pharma Dev, Université de Toulouse, IRD, UPS, Toulouse, France.
Léa Da Costa-FernandesSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0003-1272-3938
Paul MonsarratSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Bruno SéguiUMR 1037, Centre de recherche en cancérologie de Toulouse (CRCT), Université de Toulouse, INSERM, UPS, Toulouse, France.
Mireille AndréSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Christophe GuissardSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Marie-Laure RenoudSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0001-5812-6720
Marine SilvaInserm U1213, Université Lyon 1, Villeurbanne, France.
Gilles MithieuxInserm U1213, Université Lyon 1, Villeurbanne, France.
Isabelle Raymond-LetronSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Luc PénicaudSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Anne LorsignolSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0001-7662-1872
Louis CasteillaSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Cécile Dromard BerthézèneSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-0535-0689
Béatrice CousinSTROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France. beatrice.cousin@inserm.fr.ORCID http://orcid.org/0000-0003-2952-4601
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR 16-CE14-0006-01Fondation pour la Recherche Médicale (Foundation for Medical Research in France) FDT201904008033
6 · The paper itself

Abstract

Tissue repair after lesion usually leads to scar healing and thus loss of function in adult mammals. In contrast, other adult vertebrates such as amphibians have the ability to regenerate and restore tissue homeostasis after lesion. Understanding the control of the repair outcome is thus a concerning challenge for regenerative medicine. We recently developed a model of induced tissue regeneration in adult mice allowing the comparison of the early steps of regenerative and scar healing processes. By using studies of gain and loss of function, specific cell depletion approaches, and hematopoietic chimeras we demonstrate here that tissue regeneration in adult mammals depends on an early and transient peak of granulocyte producing reactive oxygen species and an efficient efferocytosis specifically by tissue-resident macrophages. These findings highlight key and early cellular pathways able to drive tissue repair towards regeneration in adult mammals.

Identifiers

PMID34344890
PMCPMC8333253
OpenAlexW3188064727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.